HOPA MVZ GmbH

Hamburg 8 trials 1 recruiting

8 Registered trials

1 Currently recruiting

Organisation

HOPA MVZ GmbH

Location

Hamburg, Germany

Identifier

ORG-100041464

Address

Moerkenstrasse 47, Altona-Altstadt, 22767, Germany

Departments

Haematologisch-Onkologische Praxis Altona
Hämatologisch-Onkologische
Hämatologisch-Onkologische Praxis Altona (HOPA)
Hematology and Oncology
Internal Medicine, Haematology, Oncology, and Palliative Medicine
NA
Oncology

Clinical trials at this site (8)

Search interface

Discontinuation of CDK4/6 inhibitors in patients with metastatic HR positive, HER2 negative breast cancer with durable disease control: A ra… Recruiting

2023-504141-31-00 Metastatic HR positive, HER2 negative breast cancer 4 2024-01-17
A study to determine if ALXN2220 is effective, safe, and tolerable in adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Ended

2023-506669-70-00 Adults with Transthyretin Amyloid Cardiomyopathy (ATTR- 5 2024-04-30
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis. Ended

2022-503072-84-00 stage IIIa cardiac AL amyloidosis 5 2021-02-13
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis Ended

2022-503073-11-00 Stage IIIb cardiac AL amyloidosis 5 2021-02-13
Further 2 years of adjuvant imatinib may improve recurrence-free survival (RFS) of patients who are at a high risk of GIST recurrence despit… Ended

2024-512243-23-00 gastrointestinal stromal tumor 5 2014-11-07
Efficacy of [18F]florbetaben PET for diagnosis of cardiac AL amyloidosis Ended

2022-500186-27-00 ATTR Amyloidosis 5 2023-01-11
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexametha… Ended

2024-511967-26-00 AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis 5 2016-11-21
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15